Literature DB >> 30578481

X-linked Retinitis Pigmentosa.

Stephen H Tsang1,2, Tarun Sharma3.   

Abstract

X-linked retinitis pigmentosa (XLRP) is considered to be one of the most severe forms of retinitis pigmentosa (RP). It accounts for about 6-20% of all RP cases, including about 10% in the United States and 25% in England.

Entities:  

Keywords:  Retinitis pigmentosa; X-linked

Mesh:

Year:  2018        PMID: 30578481     DOI: 10.1007/978-3-319-95046-4_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  A novel mutation of RPGR in a Chinese family with X-linked retinitis pigmentosa.

Authors:  Hui-Hui Sun; Jing-Cong Zhao; Su-Ling Yang; Jin-Dou Shi; Yun-Shuo Wei; Jian-Cang Wang; Feng Gu; Lu Chen
Journal:  Int J Ophthalmol       Date:  2022-09-18       Impact factor: 1.645

2.  Retinal Phenotype in the rd9 Mutant Mouse, a Model of X-Linked RP.

Authors:  Antonio Falasconi; Martina Biagioni; Elena Novelli; Ilaria Piano; Claudia Gargini; Enrica Strettoi
Journal:  Front Neurosci       Date:  2019-09-19       Impact factor: 4.677

3.  Novel mutations of RPGR in Chinese families with X-linked retinitis pigmentosa.

Authors:  Zhimeng Zhang; Hehua Dai; Lei Wang; Tianchang Tao; Jing Xu; Xiaowei Sun; Liping Yang; Genlin Li
Journal:  BMC Ophthalmol       Date:  2019-11-27       Impact factor: 2.209

Review 4.  X-Chromosome Inactivation and Related Diseases.

Authors:  Zhuo Sun; Jinbo Fan; Yang Wang
Journal:  Genet Res (Camb)       Date:  2022-03-27       Impact factor: 1.588

5.  Identical IFT140 Variants Cause Variable Skeletal Ciliopathy Phenotypes-Challenges for the Accurate Diagnosis.

Authors:  Joanna Walczak-Sztulpa; Anna Wawrocka; Cenna Doornbos; Ronald van Beek; Anna Sowińska-Seidler; Aleksander Jamsheer; Ewelina Bukowska-Olech; Anna Latos-Bieleńska; Ryszard Grenda; Ernie M H F Bongers; Miriam Schmidts; Ewa Obersztyn; Maciej R Krawczyński; Machteld M Oud
Journal:  Front Genet       Date:  2022-07-07       Impact factor: 4.772

6.  Management of retinitis pigmentosa by Wharton's jelly-derived mesenchymal stem cells: prospective analysis of 1-year results.

Authors:  Emin Özmert; Umut Arslan
Journal:  Stem Cell Res Ther       Date:  2020-08-12       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.